EWM
concept 31 sources

Informed Consent

Citations audited:1 accurate 30 not yet audited
bioethics medical-ethics research-ethics
Eras twentieth-century, twenty-first-century
First appearance Nuremberg Code (1947); legal precursor in Schloendorff v. Society of New York Hospital (1914)

Summary

Informed consent is the principle that patients and research subjects must receive adequate information about proposed interventions and must agree voluntarily before receiving them. Before the mid-twentieth century, no medical tradition recognized a formal consent requirement: paternalism was medicine’s default posture. The principle gained legal footing in early twentieth-century American courts, but it became a cornerstone of ethics only after the Nuremberg Doctors’ Trial (1947) exposed the consequences of coerced human experimentation. The Nuremberg Code, the Declaration of Helsinki (1964), and the Belmont Report (1979) built successive frameworks. In clinical medicine, the parallel legal development ran through key court rulings that established a physician’s affirmative duty to disclose. Philosophers and virtue ethicists have since debated whether consent, as a procedural requirement, is sufficient protection or whether it places too much of the moral burden on a document and too little on the character of the practitioner.

Before any formal doctrine of informed consent existed, the social conditions of American slavery established consent’s structural opposite as normal medical practice. In the slaveholding United States, the planter owned the slave and employed the physician; it was the planter, not the enslaved person, who gave or withheld consent for medical procedures ranging from sterilization to amputation to autopsy. The planter, not the slave, was the patient in every important sense of the word.(Washington, Harriet A., 2006) Physicians devised strategies to overcome the resistance of enslaved experimental subjects: James Marion Sims addicted the enslaved women he operated on repeatedly to morphine, administering it only after surgery to control their post-operative behavior rather than to alleviate the pain of the procedure itself, on the logic that addiction weakened their will to resist further operations.(Washington, Harriet A., 2006) Even beyond the antebellum period, the appropriation of Black bodies without knowledge or consent persisted: as recently as 1977, a retired auto mechanic named Casper Yeagin died in Howard University Hospital, was transferred without his family’s knowledge to a medical school anatomy laboratory, and was on the verge of dissection by medical students before fingerprints identified him.(Washington, Harriet A., 2006) These cases are the historical context in which the formal consent doctrine was constructed; they illustrate what consent’s absence looked like in practice.

Pre-Modern Practice: Paternalism as the Norm

The Hippocratic tradition contained nothing resembling an obligation to obtain patient consent. As Beauchamp and Childress observe, it could not adequately address modern concerns such as informed consent, privacy, access to health care, and research involving human subjects, because professional ethics then was “ill equipped to provide an adequate framework” for a pluralistic society in which patients were moral agents with independent rights.(Tom L. Beauchamp, James F. Childress, 2013) Thomas Percival’s 1803 Medical Ethics (the foundational text of Anglo-American medical ethics and the template for the 1847 AMA Code) placed nonmaleficence and beneficence as physicians’ primary obligations while understating the patient’s role in decision-making.(Tom L. Beauchamp, James F. Childress, 2013)

The Hippocratic tradition was not hostile to patients. It was built around beneficence (doing good for the sick) and required real skill, fidelity, and compassion. What it lacked was any framework in which the patient’s own preferences could constitute a moral constraint on the physician’s judgment. The physician decided; the patient recovered. When Richard Cabot argued in 1903 that patients should be told the truth about their diagnosis and prognosis, he made his case not on grounds of patient rights but through an empirical comparison of clinical outcomes: “I have not yet found any case in which a lie does not do more harm than good.”(Jonsen, 2000) The argument for truth-telling was consequentialist, not deontological, the patient’s autonomy was not yet the organizing concept.

Despite this tradition, legal precursors to consent were older than the modern doctrine suggests. Baker identifies a legal requirement for patient consent to medical procedures as early as the Duke of York’s Law of 1665, the first law regulating health professionals in the British colonies, which stated that no physician may “presume to set forth or exercise any act contrary to the known approved rule of art … without the … consent of the patient.”(Baker, 2013) This, however, was a legal protection against medical assault, not an articulated ethical doctrine requiring disclosure of information.

The modern legal foundation for informed consent was laid in the American courts. In 1914, Justice Benjamin Cardozo ruled in Schloendorff v. Society of New York Hospital that “every human being of adult years and sound mind has a right to determine what shall be done with his own body; and a surgeon who performs an operation without his patient’s consent commits an assault for which he is liable in damages.”(Baker, 2013) The ruling was sweeping in its language but narrow in its application: it established a right to refuse unwanted touching, not an affirmative duty to disclose risks and alternatives.

The affirmative disclosure obligation (the part of consent that is specifically informed) emerged later. Washington documents that the 1947 AEC policy on radiation experiments was the first occurrence of the term “informed consent” in ethical policy, requiring that subjects understand what they were being exposed to and that next of kin also give written consent, though the policy was not widely distributed and scientists routinely violated it.(Washington, Harriet A., 2006) In law, the term “informed consent” appeared in a 1957 California case, Salgo v. Leland Stanford Jr. University Board of Trustees, in which a patient developed permanent paralysis after an aortography procedure and had not been told of the risk. The court held that a physician withholds essential information at his peril. Canterbury v. Spence (1972) later refined the standard, moving from what physicians customarily disclosed to what a reasonable patient would want to know, the patient-centered rather than physician-centered standard of disclosure. Together, these cases converted what had been a physician’s discretionary courtesy into a legally enforceable duty.

The Nuremberg Code (1947)

The Nuremberg Doctors’ Trial (one of the subsequent Nuremberg proceedings, concluded in 1947) prosecuted twenty-three German physicians for conducting murderous experiments on concentration camp prisoners without consent. The experiments included high-altitude research that deprived subjects of oxygen until death, deliberate infection with malaria, typhus, cholera, and hepatitis, battle wound simulation with bacterial infection, and systematic experiments in mass sterilization.(Jonsen, 2000)

The Tribunal’s verdict articulated ten basic principles for ethical human experimentation, which became known as the Nuremberg Code. The Code’s first words are unequivocal: “The voluntary consent of the human subject is absolutely essential.”(Jonsen, 2000) The remaining nine principles elaborated on this foundation: experiments must yield results beneficial to society that could not be obtained by other means; they must be based on prior animal studies; unnecessary suffering must be avoided; subjects must be free to withdraw at any time; and the experiment must be conducted by scientifically qualified persons.

The Nuremberg Code was a direct response to atrocity. It established the principle in research ethics but had limited immediate impact on ordinary clinical practice, where the physician-patient relationship was governed by a separate tradition. American physicians in particular distanced themselves from the Nuremberg proceedings, insisting that the Nazi doctors were criminals, not physicians, and that ordinary medicine needed no such code.(Jonsen, 2000) The Code nonetheless planted the formal language (“voluntary consent” as “absolutely essential”) that subsequent frameworks would develop.

The Declaration of Helsinki (1964)

The World Medical Association adopted the Declaration of Helsinki in 1964 to extend research ethics standards beyond the research context addressed at Nuremberg and to acknowledge that research often occurs within therapeutic relationships. Helsinki distinguished between therapeutic research (conducted for a patient’s direct benefit) and non-therapeutic research (conducted for general scientific knowledge), applying stricter standards to the latter. It required written protocols, independent committee review, and the primacy of subject welfare over the interests of science and society.

Helsinki has been revised multiple times (in 1975, 1983, 1989, 1996, 2000, 2008, and 2013) each revision responding to evolving controversies including placebo-controlled trials in developing countries and post-trial access to beneficial treatments. The recurring revisions reflect a fundamental tension: research must be conducted to advance medicine, but research subjects must not be used merely as means to others’ benefit.

The Belmont Report (1979)

The Belmont Report emerged from a specific American scandal. The Tuskegee Syphilis Study, begun by the U.S. Public Health Service in 1932 in Macon County, Alabama, enrolled 400 Black men with syphilis who were never told their diagnosis, never treated, and never informed they were research subjects, a deception that continued for 40 years, even after penicillin became available as an effective treatment.(Jonsen, 2000) When the study was exposed in 1972, the public response was sufficient to prompt Congressional action. Congress established the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, which met from 1974 to 1978 and produced the Belmont Report.(Jonsen, 2000)

The Report articulated three foundational principles: respect for persons (which requires treating individuals as autonomous agents and protecting those with diminished autonomy), beneficence (which requires maximizing benefits and minimizing harms), and justice (which requires fair distribution of research burdens and benefits). Within the respect-for-persons principle, informed consent was specified as requiring three elements: information, comprehension, and voluntariness. The Belmont framework became the basis for federal regulations governing human subjects research, codified in what is now called the Common Rule, and the appointment of Institutional Review Boards (IRBs) to oversee research protocols.(Jonsen, 2000)

Historian David Rothman observed that by 1978 bioethics had transformed not just the substance but the style of medical decision-making, establishing that medical ethics was no longer the exclusive domain of physicians.(Jonsen, 2000) The Belmont Report was a significant instrument of that transformation.

Philosophical Foundations: Autonomy and Its Requirements

The philosophical grounding of informed consent in contemporary bioethics runs through the principle of autonomy. Beauchamp and Childress, in Principles of Biomedical Ethics (1979, now in its eighth edition), identified informed consent as the primary practical expression of respect for autonomy in the clinical context. They defined informed consent in its primary sense as “an individual’s autonomous authorization of a medical intervention or of participation in research”: something more than mere compliance or agreement, an intentional authorization by a substantially understanding, noncoerced person.(Tom L. Beauchamp, James F. Childress, 2013)

The principle of respect for autonomy, on their account, imposes both a negative obligation (not to subject autonomous actions to controlling constraints) and a positive obligation (to disclose information and support adequate decision-making).(Tom L. Beauchamp, James F. Childress, 2013) The positive obligation is what distinguishes informed consent from mere consent: the physician is not simply required to refrain from acting without permission but is required to provide the information that makes genuine authorization possible.

Beauchamp and Childress specified three conditions for autonomous action: intentionality, understanding, and the absence of controlling influences. These can be satisfied to varying degrees except intentionality, which is all-or-nothing.(Tom L. Beauchamp, James F. Childress, 2013) The conditions are deliberately practical rather than idealized. A patient need not engage in higher-order reflection on whether her preferences are the preferences she would have on reflection in order for her consent to count as autonomous.(Tom L. Beauchamp, James F. Childress, 2013)

The doctrine serves multiple functions beyond the protection of autonomy. Beauchamp and Childress identified at least seven: providing transparency; allowing control and authorization; promoting concordance with participants’ values; protecting and promoting welfare interests; promoting trust; satisfying regulatory requirements; and promoting integrity in research.(Tom L. Beauchamp, James F. Childress, 2013) This plurality of functions explains why consent requirements persist even in situations where autonomy protection is achieved by other means.

The shift of emphasis from physician disclosure to patient understanding was not immediate. Beauchamp and Childress trace it: “Roughly since the Nuremberg trials … ethics in medicine and research has increasingly placed consent at the forefront of its concerns. The term informed consent did not appear until a decade after these trials and did not begin to receive detailed examination until the early 1970s. Over time the physician’s or researcher’s obligation to disclose information shifted significantly to the quality of a patient’s or subject’s understanding and consent.”(Tom L. Beauchamp, James F. Childress, 2013)

The doctrine of informed consent developed along two parallel tracks that differ in important ways.

In research, the primary ethical concern is exploitation: subjects who bear the burdens of research may not share in its benefits, and their participation must therefore be genuinely voluntary and informed. The Nuremberg Code, Helsinki, and Belmont are primarily research frameworks, addressing the investigator-subject relationship where the conflict of interest between scientific goals and subject welfare is structural.

In clinical medicine, the primary concern is paternalism: physicians who know more than their patients may make decisions that are medically correct but contrary to what patients, if fully informed, would choose. The legal doctrine from Schloendorff through Canterbury addresses this relationship.

In practice, the two tracks converge when research occurs within therapeutic relationships, the situation Helsinki specifically addressed. When a physician enrolls a patient in a clinical trial, the patient may be uncertain whether recommendations are made in the patient’s interest or the study’s interest. The combination of therapeutic and research roles creates what has been called “therapeutic misconception”: the tendency of research subjects to believe that the study is designed for their individual benefit rather than to generate generalizable knowledge.

The 1972 Patient’s Bill of Rights adopted by the American Hospital Association explicitly included the right to informed consent, bringing the research ethics framework into ordinary clinical practice.(Starr, 1982) This was a significant institutional step: consent was no longer only a protection against unethical research but a standard requirement for all medical care.

Challenges and Critiques

Several serious objections to the informed consent doctrine as ordinarily practiced have been advanced.

The capacity problem. Competence to consent is not binary but task-specific and may vary over time. A person incompetent to decide about financial affairs may be competent to decide about research participation; competence may be intermittent.(Tom L. Beauchamp, James F. Childress, 2013) The gatekeeping role of competence judgments (distinguishing whose decisions should be respected from whose require surrogate decision-making) is where much of the practical difficulty lies.(Tom L. Beauchamp, James F. Childress, 2013)

The information problem. The legal and ethical standard of disclosure has evolved, but no standard perfectly solves the problem of information asymmetry. Research by Pellegrino and Thomasma suggests that experienced clinicians can “get almost any decision they want, depending on how they use their authority and knowledge to present the choices.”(Pellegrino, 1993) If disclosure is the only constraint on influence, and if framing effects are powerful, informed consent may protect the form of autonomous choice while leaving its substance susceptible to physician influence. Pellegrino and Thomasma argue that prudential judgment (phronesis) is required to mediate between providing too much and too little information.

The cultural problem. Empirical studies show wide cross-cultural variation in attitudes toward disclosure and autonomous decision-making. Korean-American and Mexican-American patients are significantly less likely than European-American patients to believe that a patient should be told the diagnosis of metastatic cancer, and they more frequently prefer family-based decision-making.(Tom L. Beauchamp, James F. Childress, 2013) Beauchamp and Childress argue that the solution is to ask patients their individual preferences rather than to assume that cultural membership determines values: the right to decline information and delegate decisions is itself an exercise of autonomy.(Tom L. Beauchamp, James F. Childress, 2013)

The virtue objection. From within virtue ethics, both Henry Beecher and Pellegrino and Thomasma argued that informed consent, as a procedural requirement, cannot bear the full moral weight assigned to it. Beecher observed that the most reliable safeguard for experimental subjects is not consent procedures but “the presence of an intelligent, informed, conscientious, compassionate, responsible investigator.”(Pellegrino, 1993) Pellegrino and Thomasma agreed: “no contract, law, or abstract ethical principle can eradicate the need for trust.”(Pellegrino, 1993) Paternalism cannot be equated with beneficence, it violates integrity of the person and is not a beneficent act.(Pellegrino, 1993) But consent forms do not create integrity; they presuppose it. Where integrity is absent, a signed consent form does not protect the subject.

The shared decision-making question. Shared decision-making (where physician and patient deliberate together) has been promoted as a richer model than the disclosure-plus-signature procedure. But Beauchamp and Childress caution against conflating the two. Shared deliberation is a process; informed consent is an act. The authority to authorize or refuse belongs to the patient alone, “not to a physician or research investigator, even when extensive shared dialogue has occurred.”(Tom L. Beauchamp, James F. Childress, 2013)

Scholarly Assessment

Informed consent underwent a transformation from a marginal legal concept to a foundational principle of medical ethics in the space of roughly thirty years (1947–1979). The transformation was driven by three converging forces: revelations of research abuse (Nazi experiments, Tuskegee) that demonstrated the consequences of unconstrained physician authority; a broad cultural shift toward patient rights and skepticism of professional expertise; and the philosophical work of bioethicists who gave the autonomy-based argument systematic formulation.

The doctrine has succeeded in establishing a procedural baseline. No serious medical ethics framework today endorses coerced or uninformed treatment. In American medicine, the shift in disclosure practice was dramatic: in 1961, 88% of physicians sought to avoid disclosing a cancer diagnosis to patients; by 1979, 98% reported a policy of full disclosure.(Tom L. Beauchamp, James F. Childress, 2013)

What the doctrine has not resolved is deeper. Jay Katz argued that professional ethics built on vague principles is insufficient, and that a genuine engagement with patient self-determination requires more than consent procedures.(Tom L. Beauchamp, James F. Childress, 2013) The Hippocratic tradition could not address informed consent because it lacked the conceptual vocabulary.(Tom L. Beauchamp, James F. Childress, 2013) The bioethics tradition built that vocabulary, but critics from Pellegrino to feminist relational-autonomy theorists have argued that the vocabulary, as deployed in standard consent doctrine, still rests on an impoverished picture of the person: atomistic, information-processing, and insufficiently attentive to the relational and contextual conditions under which real consent occurs.

Human Notes

This page draws exclusively on evidence from the indexed library. The legal case law (Salgo, Canterbury) is mentioned in historical context but was not directly extracted from evidence cards, those claims draw on Jonsen and Baker for the narrative context. The Helsinki Declaration is not extracted in detail from any single evidence card; its content here is synthesized from the historical arc documented in Jonsen and Baker. Future enrichment should target a dedicated Helsinki/Belmont primary source.

See Also

Sources

This article draws on 31 evidence cards from 6 sources.